Delivery Order SPE2DB20D3103-SPE2DB26FL4D7
Award Date 10/28/25
Potential Completion Date 10/29/25
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,541.90 by the Defense Logistics Agency (DLA) on December 9, 2025, with an ultimate completion date of December 10, 2025. This competitive award, which carries no set-aside designation, is for the supply of Vemlidy 25 mg tablets in quantities of 30 units. The contract employs firm fixed pricing and is classified as a delivery order, indicating it derives from a larger indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 24, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $23,466.99. The contract is a non-set-aside award funded by the Defense Logistics Agency's Medical Supply Chain, with a completion date of September 25, 2025. This delivery order represents a specific fulfillment under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on October 31, 2025, for Vemlidy 25 mg tablets in a package quantity of 30 units. This competitive, non-set-aside contract carries a ceiling value of $1,198.50 and is structured as a firm fixed-price delivery order, with an ultimate completion date of November 3, 2025. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $28,609.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count units of Vemlidy 25 mg tablets, a pharmaceutical product used in hepatitis B treatment. The award, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, was made on a non-competitive basis without a set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,202.38 by the Defense Logistics Agency (DLA) on December 10, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 11, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $49,790.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Vemlidy 25 mg tablets. This is a non-set-aside award issued on December 4, 2025, with an ultimate completion date of December 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,725.36 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (quantity: 30-unit bottles). This competitively awarded, firm fixed price contract is scheduled for completion by November 28, 2025, and represents a non-set-aside procurement. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,265.45 on October 15, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30. This non-competitive delivery order is a firm fixed price contract with a completion date of October 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,511.19 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of October 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,651.77 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on November 14, 2025, with a completion date of November 17, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...